baber/WOPTO huggingface dataset:
Patent DK-0475284-T3 (DK)
Inventor: FISSENKO VLADIMIR VLADIMIROWIT
IPC: B01F23/00
Filed: 1991-09-05
Granted: 1994-08-01
Abstract: A two-phase mixture of at least two fluids which is supplied with subsonic velocity through associated feed lines (4, 3) is accelerated to sound velocity by means of a nozzle (2). Upon the exit from the narrowest cross-sectional area (6) of the nozzle (2) the two-phase mixture is expanded in an expansion chamber (10) to supersonic velocity. The two-phase mixture expanded to supersonic velocity is thereafter brought to ambient pressure substantially as a one-phase mixture after flowing off through a diffuser passage (9) by means of a shock wave built up in an outlet channel (8). The outlet channel (8) has a constant cross-sectional area the hydraulic diameter of which is as great as the hydraulic diameter of the narrowest cross-sectional area (6) of the nozzle (2) or amounts to up to the three-fold of this hydraulic diameter. An outlet (11) provided with a relief valve (22) is connected to the expansion chamber (10). After termination of a starting operation a continuous operation appears with the shock wave being stably maintained in axial direction in the outlet channel. In this manner a good mixture of the fluids can be obtained because of the angular flow and the relative velocities of the fluids, by condensation during the transition in the two-phase condition as well as by boiling and vaporization in the range of the supersonic flow and following thereto in the shock wave because of its "shattering effect".
Patent DK-0491200-T3 (DK)
Inventor: KIISKI TAPANI
IPC: B66C13/44
Filed: 1991-11-29
Granted: 1996-03-11
Abstract: The invention relates to a procedure for selecting the mode of controlling the motor of a crane or an equivalent lifting apparatus. At least two alternative modes of controlling the motor are available, at least one of the modes involving control by means of a switch having at least two positions connectable in a certain order, producing corresponding control signals in the control port, while each control mode uses at least one control signal common to all modes. According to the invention, the signals (6-9) applied to the control port are monitored, the prevailing control situation is determined on the basis of the signals (6-9) monitored and the mode of control is selected on the basis of the signals (6-9) and the prevailing control situation. <IMAGE>
Patent DK-0540639-T3 (DK)
Inventor: LIGHT FRED WINIFRED JR
IPC: C08G18/40
Filed: 1991-07-15
Granted: 1995-11-13
Abstract: Disclosed are powder coating compositions comprised of one or more semi-crystalline polyesters, one or more amorphous polyesters and one or more hydroxyl acrylic polymers and a blocked polyisocyanate cross-linking agent. Coatings of the compositions on shaped metal articles exhibit an ASTM D-523-85 60 DEG  gloss value of not greater than 35, ASTM D2794-84 front/back impact strength values of at least 40/20 inch-pounds, an ASTM D-3359-83 cross-hatch adhesion pass percent value of at least 90, a pencil hardness of at least H and an ASTM 4145-83 flexibility of 2T or better.
Patent DK-0550523-T3 (DK)
Inventor: RIESS SIEGFRIED
IPC: G01N1/10
Filed: 1991-09-24
Granted: 1995-04-24
Abstract: The description relates to a process for obtaining and handling samples and a device for implementing it, whereby it is to be ensured that a representative sample is possible from a through-flow line and the samples can be transferred to, kept in and extracted from the sample flask in sterile and isobarometric conditions. Among the measures of the process therefor, the sample flask in the closed, pressure-tight state is pressure-proofly connected to a sample tapping device (3) fitted on a through-flow line (1), a first connecting path (6) between the inside of the sample flask (2) and the sample tapping device (3) of the through-flow line (1) and a second connecting path (7) between the inside (20) is opened, the inside of the sample flask (2) is rinsed by the supply of a suitable gas from a gas line (16) connected to a foreign gas source (14) via both connecting paths (6, 7) and its content is replaced by said gas, the inside of the sample flask (2) is released at the end of the sampling process while maintaining the static pressure of the sample tapping device (3) and is thereby pressure-tightly closed and the volume of the sample is taken from the sample flask (2) while maintaining the static pressure and in sterile conditions and taken to an analysis device. The device includes a valve block (35) in which are produced the essential precautions for sampling in the form of the valves (11, 12, 13) arranged within it, by means of their seats (35d or 35e or 35f) and by means of the lines in it like the inlet line (19), the gas lines (16, 16a, 16b), the pressure equalising line (20) and the outlet line (21).
Patent DK-0509259-T3 (DK)
Inventor: WEINTRAUB PHILIP M
IPC: A61P13/02
Filed: 1992-03-18
Granted: 1996-09-09
Abstract: Described is the use of compounds of the general formula I <CHEM> wherein the dotted lines indicate the optional presence of a double bond, R is -(C1-6 alkyl)-OZ or -(C2-6 alkyl)-(OZ)2 and Z is hydrogen, C1-6 alkyl, phenyl-(C1-4 alkyl), (Y-substituted phenyl)-(C1-4 alkyl), C1-6 alkanoyl, benzoyl or Y-substituted benzoyl wherein Y is methyl, halogen or methoxy, for the preparation of a pharmaceutical composition for inhibiting C17-20 lyase enzyme and for treating androgen-dependent disorders.
Patent DK-0581848-T3 (DK)
Inventor: BLUMENFELD MARTA
IPC: A61K48/00
Filed: 1992-04-24
Granted: 2003-10-27
Abstract: The present invention concerns the use of a double-stranded closed oligonucleotide containing a binding site for a given transcription factor, e.g. HNF-1 factor, for inhibiting the expression of a given gene under the control of said transcription factor, e.g. liver-specific genes coding for fibrinogen, transthyretin, apolipoprotein B or the pre-S1 gene of hepatitis B virus. Particularly preferred oligonucleotides are the ones containing the sequence 5'GTTANT3', wherein N can be any of A,T,C or G.
Patent DK-0569167-T3 (DK)
Inventor: GREEN BOBBY EARL
IPC: B65D1/02
Filed: 1993-04-23
Granted: 1997-10-27
Abstract: A container (10) for a viscous food product having a configuration which enables relatively uniform heating of the contents at an acceptable rate without scorching in a conventional microwave oven. The preferred container is made from an electrically nonconductive material having a generally ovate bottom wall (24) and a side wall (12) extending upward therefrom to an upper end portion. The side wall may have a substantially ovate cross-section (14,16) over substantially its entire height. The ovate cross-section may have a width-to-depth ratio of approximately 2:1 over substantially its entire height. The upper end portion may convexly decrease in width proceeding upward on the container. <IMAGE>
Patent DK-0671933-T3 (DK)
Inventor: RENNICK DONNA
IPC: A61P1/00
Filed: 1993-08-18
Granted: 1998-09-23
Abstract: IL-10 alone, or optionally in combination with IL-4, are provided for use in the manufacture of pharmaceutical compositions for inhibiting delayed-type hypersensitivity reaction.
Patent DK-0662129-T3 (DK)
Inventor: THOMAS WAYNE R
IPC: C12R1/19
Filed: 1993-09-10
Granted: 1998-03-30
Abstract: The present invention features isolated DNA encoding allergens of Dermatophagoides (house dust mites) particularly of the species Dermatophagoides farinae and Dermatophagoides pteronyssinus, which are protein allergens or peptides which include at least one epitope of the protein allergen. In particular, the invention provides DNA encoding the major D. farinae allergens, Der f I and Der f II and DNA encoding the major D. pteronvssinus allergens, Der p I and Der p II. The present invention further relates to proteins and peptides encoded by the isolated D. farinae and D. pteronvssinus DNA, including proteins containing sequence polymorphisms. In addition, the proteins or peptides encoded by the isolated DNA, their use a diagnostic and therapeutic reagents and methods of diagnosing and treating sensitivity to house dust mite allergens, are disclosed.
Patent DK-0711359-T3 (DK)
Inventor: RAMBACH ALAIN
IPC: C12R1/01
Filed: 1994-07-28
Granted: 1997-12-08
Abstract: PCT No. PCT/FR94/00957 Sec. 371 Date Jan. 26, 1996 Sec. 102(e) Date Jan. 26, 1996 PCT Filed Jul. 28, 1994 PCT Pub. No. WO95/04156 PCT Pub. Date Feb. 9, 1995A method for revealing the presence or absence of a particular microorganism strain in a medium, wherein at least one strain enzyme substrate chromogen and at least one compound selected from a high-concentration carbohydrate are added to the culture medium so that a derived colour differing from the basic colour of the chromophore is obtained once the chromogen has been hydrolysed.
Patent DK-0730460-T3 (DK)
Inventor: PERSSON LARS
IPC: A61K31/66
Filed: 1994-11-18
Granted: 2002-09-23
Abstract: PCT No. PCT/SE94/01095 Sec. 371 Date Jul. 22, 1996 Sec. 102(e) Date Jul. 22, 1996 PCT Filed Nov. 18, 1994 PCT Pub. No. WO95/14477 PCT Pub. Date Jun. 1, 1995The present invention relates to the use of an ester of inositoltrisphosphate for the preparation of a medicament for preventing, alleviating or combatting inflammatory conditions in mammals including man. Injury or destruction of tissues should be understood as damage to an aggregation of specialized cells with a particular function both internally and externally in the body, such as different organs or parts of these, vessels, skin etc. Tissue damage involves a complex series of events such as dilatation of vessel walls e.g. arterioles, capillaries and venules, increased permeability of fluids including e.g. plasma proteins and increased blood flow. Increased vascular leakage often results in extravasation and oedema formation which characterize the damage of different tissues. Often tissue damage and inflammatory conditions are characterized by signs of pain, heat, redness, swelling and loss of function. Tissue damage is not defined as a disease per se but is often a component in different diseases of both acute or chronic nature.
Patent DK-0798971-T3 (DK)
Inventor: GREENHAFF PAUL LEONARD
IPC: A23L1/305
Filed: 1995-12-15
Granted: 2000-11-13
Abstract: PCT No. PCT/GB95/02933 Sec. 371 Date Sep. 29, 1997 Sec. 102(e) Date Sep. 29, 1997 PCT Filed Dec. 15, 1995 PCT Pub. No. WO96/18313 PCT Pub. Date Jun. 20, 1996Compositions herein increased creatine retention and/or glycogen storage in muscle. A composition comprises creatine or its derivative and a carbohydrate or its derivative. The carbohydrate is in an amount by weight which is greater than the amount of creatine. The amount of carbohydrate and the amount of creatine are effective for increasing creatine retention and/or glycogen storage in muscle. The compositions may be in the form of a pharmaceutical or a dietary supplement and are intended for use in the human or animal body. Other compositions comprise creatine or an active derivative together with insulin or an active derivative. The amount of creatine and the amount of insulin are effective for increasing creatine retention and/or glycogen storage in muscle. The compositions including creatine and insulin may further contain a carbohydrate or its derivative. A method of increasing creatine retention in a human or animal body comprises causing an increase in blood plasma creatine concentration and causing a substantially simultaneous increase in blood plasma insulin concentration. A method of increasing glycogen storage in a human or animal body comprises causing an increase in blood plasma creatine carbohydrate concentration and causing a substantially simultaneous increase in blood plasma creatine concentration. The compositions to increase the creatine retention and/or glycogen storage in the muscle are administered by injection or ingestion.
Patent DK-0817646-T3 (DK)
Inventor: MCFADDEN D GRANT
IPC: A61P9/00
Filed: 1996-03-26
Granted: 2003-04-22
Abstract: Compositions and methods for treating inflammatory cell infiltration in a tissue of a mammalian subject are provided. The method involves administering a therapeutically effective amount of SERP-1, SERP-1 analog or biologically active fragment thereof admixed with a pharmaceutically acceptable carrier to a subject in need of such treatment. Biologically active SERP-1 analogs are also provided. The compositions and methods of the present invention are useful for treating numerous inflammatory based diseases and injuries.
Patent DK-0785336-T3 (DK)
Inventor: WYLIE DOUGLAS H
IPC: C03C27/06
Filed: 1997-01-22
Granted: 2000-10-30
Abstract: The spacer defines an insulated space between the panes and includes a top bridge member, first and second metallic leg members, a bottom bridge member and a channel portion. The top bridge member is provided for contacting the inner and outer panes of the window unit. The top bridge member is made of a synthetic resin or composite material and can include openings. Perforated extensions of the first and second leg members are secured to the top bridge member. The first and second leg members can be bent into a zig-zag configuration. The bottom bridge member is parallel to the top bridge member and cooperates with the first and second leg members. The channel portion is defined by the configuration of the top bridge member, the first and second leg members and the bottom bridge member.
Patent DK-0914095-T3 (DK)
Inventor: BURKE PAUL A
IPC: A61K38/28
Filed: 1997-05-01
Granted: 2002-11-11
Abstract: The present invention includes a method for producing an implantable polymer/drug matrix mass, comprising the steps of (1) forming a polymer solution/drug mixture comprising a polymer dissolved in an organic solvent and a suspended labile drug; (2) removing the solvent from the polymer solution/drug mixture, thereby forming a solid polymer/drug matrix; and (3) mechanically compressing the polymer/drug matrix, thereby forming an implantable polymer/drug matrix mass.
Patent DK-0910927-T3 (DK)
Inventor: GERHAEUSER HEINZ
IPC: H04H20/88
Filed: 1997-06-03
Granted: 2000-05-08
Abstract: A method of coding stereo audio spectral values first carries out grouping of those values in scale factor bands, with which scale factors are associated. Sections are formed next, each comprising at least one scale factor band. The spectral values are coded within at least one section with a code book assigned to the section, out of a plurality of code books each with a code book number assigned to it, the number of the code book used being transmitted as side information to the coded stereo audio spectral values. At least one additional code book number is provided, which does not refer to a code book but shows information relevant to the section to which it is assigned. A method of decoding stereo audio spectral values which are partly coded by the intensity stereo process and which have side information uses the relevant information, showing the additional code book numbers, to cancel the existing coding of the stereo audio spectral values.
Patent DK-0874700-T3 (DK)
Inventor: HOFMANN HERMANN
IPC: B09B3/00
Filed: 1997-10-21
Granted: 2003-04-28
Abstract: In a process and assembly to separate a mixture of waste materials, the novelty is that: (a) the mixture is first composted pref. under conditions of force-fed air and/or is stabilised; (b) the components of the resulting mixture are then separated into a combustible fraction and an incombustible fraction; (c) the fractions are separated by sieve, winnowing or fluid classification; (d) the mixture is crushed or shredded into particles, or homogenised, before biological treatment; and (e) valuable materials are first removed before the biological or homogenisation treatments.
Patent DK-1062188-T3 (DK)
Inventor: GUINDON LOUISE
IPC: C06B45/34
Filed: 1998-03-06
Granted: 2008-12-01
Abstract: A non-toxic primer composition for use in ammunition is provided with a hygroscopic oxidizer which is protected from absorption of water vapor by a water-barrier coating. A preferred oxidizer is potassium nitrate and a preferred coating is nitrocellulose.
Patent DK-1003536-T3 (DK)
Inventor: HIDVEGI MATE
IPC: A23L1/30
Filed: 1998-08-11
Granted: 2003-03-03
Abstract: The invention concerns an immunostimulatory and metastasis inhibiting fermented, dried vegetal material, pharmaceutical compositions containing the latter, the production process and the use of the dried material in the production dietary supplement and of immunostimulatory and metastasis inhibiting pharmaceutical compositions. The material according to the invention can be obtained by fermentation of wheat germ in an aqueous medium in the presence of Sacharomyces cerevisiae and by drying the fermented liquid.
Patent DK-0971357-T3 (DK)
Inventor: COOKSON CHRISTOPHER J
IPC: H04N5/76
Filed: 1994-10-13
Granted: 2002-01-28
Abstract: A system (41) for playing a selected one of multiple audio tracks recorded in synchronized fashion with a motion picture on an optical disk (23). The optical disk (23) has encoded on it a mixing master music and effects ("M&E") track, or a switching master M&E track. Individual audio tracks are provided for language-specific versions of the same motion picture, but these tracks have data recorded in them only where there is dialog. In this way, for many a motion picture, all tracks but masters will have data recorded for well less than half of the running time of the motion picture. When a mixing master is used, it is mixed with a language-specific track when the latter has dialog the mixing master contains no dialog. If a switching master is used, it may contain dialog recorded with the M&E when a language-specific track has dialog recorded in it, it also contains M&E and the track is played to the exclusion of the switching master.
Patent DK-1068241-T3 (DK)
Inventor: IDUSOGIE ESOHE EKINADUESE
IPC: C07K16/18
Filed: 1999-03-31
Granted: 2008-02-04
Abstract: A variant of a polypetide comprising a human IgG Fc region is described, which variant comprises an amino acid substitution at one or more of amino acid positions 270, 322, 326, 327, 329, 331, 333 or 334 of the human IgG Fc region. Such variants display altered effector function. For example, C1q binding and/or complement dependent cytotoxicity (CDC) activity may be altered in the variant polypeptide. The application also discloses a variant of a parent polypeptide comprising a human IgG Fc region, which variant has a better binding affinity for human C1q than the parent polypeptide.
Patent DK-0994923-T3 (DK)
Inventor: SAMANOS JACQUES
IPC: E01C7/18
Filed: 1999-05-07
Granted: 2006-06-06
Abstract: The present invention relates to a process for the manufacture of an emulsion of bituminous binder, comprisinga) the preparation of a concentrated primary. emulsion containing a surfactant and at least 65% by weight in the case of an anionic emulsion, or at least 70% by weight in the case of the other emulsions, of bituminous binder, by mixing an initial aqueous phase and a liquid bituminous phase under the effect of a mechanical shear energy and in the presence of the said surfactant; andb) the addition of an aqueous dilution phase to the said primary emulsion.
Patent DK-1089638-T3 (DK)
Inventor: KL SEXTRO FRANZ-JOSEF
IPC: A23N17/00
Filed: 1999-06-10
Granted: 2003-11-17
Abstract: For preparing cattle feed mixtures, especially pumpable liquid feed mixtures, the feed components are added consecutively to a weighing and mixing container and mixed. Before or while the feed mixture is being prepared, the pH of the mixture is measured and, if it exceeds a specified value during a continued mixing process, acid is added as the last additive to the feed mixture until the specified value is reached. For this purpose, a pH measuring probe, which is passed through the wall of the container, is provided in the lower region of the weighing and mixing container.
Patent ES-2203365-T3 (ES)
Inventor: SALMON NICHOLAS JAMES
IPC: G02B21/36
Filed: 2000-04-06
Granted: 2004-04-16
Abstract: A computer controlled microscope is provided with improved usability, which allows a user to quickly build, modify and reuse complex sample illumination and/or observation processes by introducing a recordings hierarchy in which a recording can be both a parent recording of one or more child recordings and a child recording to a single parent recording. A recordings hierarchy allows control parameter data to be inherited from a parent recording to a child recording. The group of child recordings linked to a parent recording is called a recordings collection. Viewed together, recordings and recordings collections form a tree-like hierarchy. Single load and store functions associated with a recording permit the entire recording and child recordings hierarchy to be stored on a storage device and reloaded into the computer of a computer controlled microscope. <IMAGE>
Patent ES-2219223-T3 (ES)
Inventor: GESTERMANN FRITZ DR
IPC: C25B1/34
Filed: 2000-05-30
Granted: 2004-12-01
Abstract: The invention relates to a process for the electrolysis of sodium chloride-containing brine with parallel operation of amalgam electrolysis units (5) and membrane electrolysis units (4) with a common brine circuit using a mercury-resistant oxygen consumable cathode in the membrane electrolysis unit (4).
Patent ES-2208189-T3 (ES)
Title: Dispositivo obturador para un rodamiento.
Inventor: FUJIMOTO KAZUYA
IPC: F16J15/324
Filed: 2000-07-04
Granted: 2004-06-16
Abstract: Un dispositivo obturador (7) para un rodamiento, el cual es un dispositivo obturador anular para ser dispuesto en una porción de cara extrema de un rodamiento para el cuello de un cilindro laminador en un tren de laminación, que incluye un núcleo anular (72), en el que una porción circunferencial exterior que incluye un anillo cilíndrico del núcleo anular (72) es retenida en un lado de un anillo de rodadura exterior, un anillo similar a un disco del núcleo anular (72) se extiende en dirección radial hacia dentro y está dispuesto en una porción extrema del citado anillo cilíndrico, un labio elástico principal (711) el cual está en contacto, en dirección circunferencial, con una cara circunferencial exterior en la proximidad de una porción extrema de un anillo de rodadura interior (1a), está formado en una porción circunferencial interior del anillo similar a un disco del citado núcleo anular (72), un labio secundario elástico (712) está formado sobresaliendo en un lado axialmente interior del citado labio elástico principal (711), separado del citado labio elástico principal (711) por una distancia predeterminada, caracterizado porque la porción circunferencial interior incluye una porción extrema de menor diámetro del anillo similar a un disco, el labio secundario elástico está dirigido desde la citada porción extrema de menor diámetro del citado anillo similar a un disco hacia una circunferencia interior, el citado labio secundario elástico (712) tiene un espesor que es menor que el espesor de una sección axial del citado labio elástico principal (711), siendo el citado labio secundario elástico (712) más corto que el citado labio elástico principal, una cara lateral del citado labio está en contacto ligero en dirección circunferencial con una cara extrema exterior de una porción de pestaña (11a) en la proximidad de la porción extrema del anillo de rodadura interior (1a) y un recinto anular para grasa está formado entre el citado labio secundario elástico (712) y el citado labio elástico principal (711).
Patent ES-2173071-T3 (ES)
Inventor: ROULIER VERONIQUE
IPC: A61K8/00
Filed: 2000-03-21
Granted: 2002-10-16
Abstract: Expanded products comprising an emulsion containing air or inert gas to give mousse-like consistency, containing at least on amphiphilic polymer and at least one anionic surfactant. An expanded composition comprising, in a physiologically acceptable medium, an oil phase dispersed in an aqueous phase containing sufficient air or inert gas to give a density of 0.2-0.8 (0.4-0.75), and containing at least one amphiphilic polymer and at leas one anionic surfactant.